Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines

We performed an independent comparison of neutralizing and cross-neutralizing antibody (ab) levels seven months after initiation of three-dose, six-month vaccination schedules with the bivalent and quadrivalent human papillomavirus (HPV) vaccines in adolescent Finnish and Indian females, respectivel...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:NPJ Vaccines
Main Authors: Mariz, Filipe Colaço, Bender, Noemi, Anantharaman, Devasena, Basu, Partha, Bhatla, Neerja, Pillai, Madhavan Radhakrisna, Prabhu, Priya R., Sankaranarayanan, Rengaswamy, Eriksson, Tiina, Pawlita, Michael, Prager, Kristina, Sehr, Peter, Waterboer, Tim, Müller, Martin, Lehtinen, Matti
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Brief Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021830/
https://ncbi.nlm.nih.gov/pubmed/32128255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-020-0165-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki